EricLMattesonMD
Rheumatology • Rochester, MNRheumatoid Arthritis & Related, Spondyloarthropathy, Vasculitis
Consultant, Chair, Division of Rheumatology, Mayo Clinic
Dr. Matteson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
201 W Center St
Rochester, MN 55902Phone+1 507-255-5123Fax+1 507-255-3125- Is this information wrong?
Summary
- Dr. Eric Matteson is a rheumatologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from University of Erlangen- Nuremberg Faculty of Medicine and has been in practice 35 years. He specializes in rheumatoid arthritis & related, spondyloarthropathy, and vasculitis.. He is retired from clinical practice.
Education & Training
University of North Carolina HospitalsFellowship, Public Health and General Preventive Medicine, 1989 - 1990
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Rheumatology, 1988 - 1989
University of Michigan Health SystemFellowship, Rheumatology, 1986 - 1988
Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1983 - 1986
University of Erlangen - Nuremberg Faculty of MedicineClass of 1982
Certifications & Licensure
MN State Medical License 1988 - 2024
AZ State Medical License 1992 - 2019
IA State Medical License 1984 - 2018
FL State Medical License 1992 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis Start of enrollment: 2008 Dec 01
- Rituximab in Rheumatoid Arthritis Lung Disease Start of enrollment: 2007 May 01
- FolateScan in Autoimmune Disease Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis.Midol, C., Wiebe, E., Siegert, E., Huscher, D., Béhal, H., Launay, D., Hachulla, E., Buttgereit, F., Sobanski, V., Matteson, E.> ;Rheumatology. 2024 Mar 7
- Referral of patients with suspected polymyalgia rheumatica: how complete is our view of 'planet PMR?'Dario Camellino, Eric L Matteson> ;Annals of the Rheumatic Diseases. 2024 Feb 28
- Associations between plasma metabolism associated proteins and future development of giant cell arteritis: results from a prospective study.Wadström, K., Jacobsson, L., Mohammad, A., Jakobsson, M., Turesson, C., Warrington, K., Matteson, E.> ;Rheumatology. 2024 Feb 3
- Join now to see all
Journal Articles
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseaseJay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, Aryeh Fischer, Michael Holers, Eric L Matteson, Timothy B Niewold, The New England Journal of Medicine
Other
- Polymyalgia Rheumatica and Giant Cell ArteritisEric Matteson, MD, JAMA
https://www.doximity.com/articles/7ee16cad-211f-44f7-a6b4-d18555291beb
UpToDate, Wolters Kluwer Health - 2012-12-17 - Prevention of Glucocorticoid Morbidity in Giant Cell ArteritisEric Matteson, MD, Rheumatology
https://www.doximity.com/articles/da91256c-6819-48b7-884a-8b2373d6753d
UpToDate, Wolters Kluwer Health - 2013-01-14
Authored Content
- Treatments for Giant Cell Arteritis: Meta-Analysis and Assessment of Estimates Reliability Using the Fragility IndexJanuary 2018
Press Mentions
New Study Finds Rheumatology Prescribing, Spending Linked to Pharmaceutical PaymentsApril 19th, 2022- Nintedanib Slows FVC Decline in Autoimmune-Related Interstitial Lung DiseaseFebruary 24th, 2022
- Is Rheumatoid Arthritis Genetic—and Does Family History Boost Your Risk?August 11th, 2021
- Join now to see all
Grant Support
- Genetic Polymorphisms In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
- Genetic Polymorphisms In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2003
- Two Week Induction Course &One Maintenance Cycle Of Ag4263National Center For Research Resources1999–2002
- Induction Therapy For Treatment Of Refractive, Active Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Study Of Campath-1h In Active Refractory Rheumatoid ArthritisNational Center For Research Resources1993
- OPEN Label Protocol Of Campath 1H In The Treatment Of Rheumatoid ArthritisNational Center For Research Resources1993
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
